Ongoing research shows Bovacillus™ from Chr. Hansen supports optimal health, productivity, and feed efficiency of dairy animals in every life stage, with more animals “simply being normal.”

Introduced in the U.S. in early 2021, the product combines select strains of Bacillus licheniformis and Bacillus subtilis. These strains have the capacity to directly influence nutrient digestibility and potentially decrease the burden of harmful bacteria.

Moreover, these spore-forming probiotic strains are resilient — durable and resistant to heat — able to withstand conventional feed processing, including steam-conditioned pelleting.

Bovacillus™ spores remain viable during feed processing, transport, and storage, then germinate in the animal and go to work. Research demonstrates that daily feeding:
• Supports feed efficiency and energy corrected milk
• Produces enzymes that may enhance fiber, fat, and starch digestibility
• Potentially reduces harmful bacteria to maintain a normal, healthy gut

Probiotic effects of Bovacillus™ include inhibiting the growth of a broad range of pathogenic bacteria. A controlled in-vivo study of calves challenged with high doses of Clostridium perfringens Type A showed improved health.

The resilience and versatility of Bovacillus™ make it ideal for a wide range of feeding applications:
• Premixes
• Mineral supplements
• Mash feeds, pellets, cubes
• Milk replacers and pasteurized milk
• Liquid feeds, blocks, tubs

Bovacillus™ is non-GMO, antibiotic-free, and OMRI Listed® for certified organic production, handling, and processing. Chr. Hansen bacterial strain production is FAMI-QS and ISO certified.

For details about Bovacillus™ research and applications, please contact: Dan Bates, mobile 989-225-0200, email usdaba@chr-hansen.com.